Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to -$13.1 million.

  • Pulse Biosciences' Free Cash Flow fell 4457.07% to -$13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.8 million, marking a year-over-year decrease of 4304.9%. This contributed to the annual value of -$36.5 million for FY2024, which is 996.92% down from last year.
  • As of Q3 2025, Pulse Biosciences' Free Cash Flow stood at -$13.1 million, which was down 4457.07% from -$12.9 million recorded in Q2 2025.
  • Over the past 5 years, Pulse Biosciences' Free Cash Flow peaked at -$6.6 million during Q1 2023, and registered a low of -$16.5 million during Q2 2021.
  • Over the past 5 years, Pulse Biosciences' median Free Cash Flow value was -$10.7 million (recorded in 2022), while the average stood at -$11.1 million.
  • As far as peak fluctuations go, Pulse Biosciences' Free Cash Flow plummeted by 10921.45% in 2021, and later skyrocketed by 5836.33% in 2023.
  • Over the past 5 years, Pulse Biosciences' Free Cash Flow (Quarter) stood at -$12.8 million in 2021, then skyrocketed by 37.59% to -$8.0 million in 2022, then rose by 14.75% to -$6.8 million in 2023, then tumbled by 34.75% to -$9.2 million in 2024, then tumbled by 42.45% to -$13.1 million in 2025.
  • Its last three reported values are -$13.1 million in Q3 2025, -$12.9 million for Q2 2025, and -$13.6 million during Q1 2025.